Open emilliman5 opened 1 year ago
Agree! It's a good list.
- Consistency and completeness: implement assessment/metrics for as many ref_source types as possible
Created a few issues we discussed that are associated with # 1. Specifically, #300, #299, and #294. #296 is sort of related... it's within the same family.
I also love # 4 proposed by @parmsam-pfizer: helping users (especially newbies) get to the risk score faster with a wrapper function. I think implementing #299 will help take away some of the pain points / reservations associated with with a wrapper function since the pkg_ref
cache would be populated with the maximum assessment info, presenting a risk score not burdened with the drawbacks of any one pkg_ref
source type.
Here are my thoughts on totential goals/strategy for 2023 (or next 1 year). Any and all input is welcome. This initial list is meant to start the discussion.
1) Consistency and completeness: implement assessment/metrics for as many ref_source types as possible 2) Implementation paradigm for 3rd party packages: see #272 3) Cohort metrics implementation and rollout, scoring a set of packages in its totality: #248, #199 #198 #174 #160 4) Enable ease of use: wrapper function #276 , expand ref_source types (e.g. PositPM, pharmaVerse), reporting/output functionality
Please feel free, to add any priorities you think should be considered, or comment on the ones suggested here.